293 related articles for article (PubMed ID: 31848037)
1. Potential role of cannabidiol for seizure control in a patient with recurrent glioma.
Hsu K; Whitham E; Kichenadasse G
J Clin Neurosci; 2020 Jan; 71():275-276. PubMed ID: 31848037
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V; Reddy DS
Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia.
Neubauer D; Perković Benedik M; Osredkar D
Epilepsy Behav; 2018 Apr; 81():79-85. PubMed ID: 29526578
[TBL] [Abstract][Full Text] [Related]
5. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
Reddy DS
Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
Hess EJ; Moody KA; Geffrey AL; Pollack SF; Skirvin LA; Bruno PL; Paolini JL; Thiele EA
Epilepsia; 2016 Oct; 57(10):1617-1624. PubMed ID: 27696387
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
Savage TE; Sourbron J; Bruno PL; Skirvin LA; Wolper ES; Anagnos CJ; Thiele EA
Epilepsy Res; 2020 Feb; 160():106263. PubMed ID: 31923763
[TBL] [Abstract][Full Text] [Related]
9. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
Uliel-Sibony S; Hausman-Kedem M; Fattal-Valevski A; Kramer U
Brain Dev; 2021 Jan; 43(1):89-96. PubMed ID: 32713661
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol for Epilepsy: New Hope on the Horizon?
Sanmartin PE; Detyniecki K
Clin Ther; 2018 Sep; 40(9):1438-1441. PubMed ID: 30150078
[TBL] [Abstract][Full Text] [Related]
12. Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.
Golub V; Ramakrishnan S; Reddy DS
Exp Neurol; 2023 Feb; 360():114294. PubMed ID: 36493860
[TBL] [Abstract][Full Text] [Related]
13. The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy.
Warren PP; Bebin EM; Nabors LB; Szaflarski JP
Neurocase; 2017; 23(5-6):287-291. PubMed ID: 29063814
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.
Hausman-Kedem M; Menascu S; Kramer U
Brain Dev; 2018 Aug; 40(7):544-551. PubMed ID: 29674131
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol as potential treatment in refractory pediatric epilepsy.
Paolino MC; Ferretti A; Papetti L; Villa MP; Parisi P
Expert Rev Neurother; 2016; 16(1):17-21. PubMed ID: 26567560
[TBL] [Abstract][Full Text] [Related]
16. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
17. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol in treatment of refractory epileptic spasms: An open-label study.
Herlopian A; Hess EJ; Barnett J; Geffrey AL; Pollack SF; Skirvin L; Bruno P; Sourbron J; Thiele EA
Epilepsy Behav; 2020 May; 106():106988. PubMed ID: 32169600
[TBL] [Abstract][Full Text] [Related]
20. Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.
Szaflarski M; Hansen B; Bebin EM; Szaflarski JP
Epilepsy Behav; 2017 May; 70(Pt B):364-369. PubMed ID: 28236578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]